Perceptimed Founder Jacobs To Speak At Bio2device Group Event
PERCEPTIMED FOUNDER JACOBS TO SPEAK AT BIO2DEVICE GROUP EVENT
MOUNTAIN VIEW, CA – April 25, 2014 – “Preventing Drug-Related Patient Injury and Death with Advanced, Cost-Effective Technology” is the topic Alan Jacobs, M.D., Ph.D., CEO and founder of PerceptiMed, will address at the Bio2Device lecture. The lecture will take place May 6th at the Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA at 8:30 a.m.
Each year more than 800,000 preventable drug-related injuries occur in long-term care facilities in the U.S. Additionally, national studies of retail pharmacy prescription-dispensing accuracy document an average error rate of 1.7%, or more than 68 million errors overall, with 4.4 million of them having the potential to cause serious harm.
Innovative, cost-effective systems for medication dispensing and administration in long-term care facilities and pharmacies are urgently needed to prevent these serious errors.
Dr. Jacobs is the co-inventor of the VeriFill IdentRx medication verification system, which removes the margin for human error in oral medication dispensing and administration. He will discuss how new technologies such as this will help eliminate the factor of human error in prescription pill dispensing.
Dr. Alan Jacobs has extensive experience leading international teams in the research and development of therapeutics and medical devices. He received a B.S.E.E. from Cornell University and a M.S.E.E from Stanford University. He also holds a Medical Doctorate from the School of Medicine at University of Pennsylvania and a Ph.D. from the David Mahoney Institute of Neuroscience, University of Pennsylvania, where he was a Fellow in the Medical Scientist Training Program of the National Institute of General Medical Sciences. Dr. Jacobs completed an internship in General Surgery and was a resident in neurological surgery at the University of California, San Francisco Medical Center.